An Investigation Of The Relationship Between The Pharmaceutical Industry, Medical Profession And Medical Practitioners
Funder
National Health and Medical Research Council
Funding Amount
$186,449.00
Summary
In recent years there has been a rapid expansion in the number and range of interactions between the pharmaceutical industry and the medical profession. While this has the potential to advance research, education and health care, there are risks that such interactions may inappropriately serve commercial objectives and ultimately compromise the best interests of patients and society in general. Most major medical and pharmaceutical organisations have released guidelines of policy statements on t ....In recent years there has been a rapid expansion in the number and range of interactions between the pharmaceutical industry and the medical profession. While this has the potential to advance research, education and health care, there are risks that such interactions may inappropriately serve commercial objectives and ultimately compromise the best interests of patients and society in general. Most major medical and pharmaceutical organisations have released guidelines of policy statements on the relationship between the medical profession and the pharmaceutical industry. To date most debate has taken the form of personal observations or professional opinion , and there has been little objective research into medical industry interactions. This project aims to examine the relationship between the pharmaceutical industry, the medical profession and the medical practitioners. Specifically, the aim of this project is to establish whether this relationship as it currently exists, and as stated in guidelines from professional bodies, is appropriate in terms of justifiable ethical standards, empirical research and social perspectives. The results of this research will enable assessment of current guidelines and the development of further guidelines and regular process where appropriate.Read moreRead less
Investigation Of Tobacco Industry Efforts To Counteract Tobacco Control In Australia, 1970-2000
Funder
National Health and Medical Research Council
Funding Amount
$333,225.00
Summary
Tobacco use continues to be both the most important preventable cause of premature death and a key determinant of health inequity in Australia. Tobacco is a legally sold product which addicts many of its consumers, mostly as adolescents, and then kills half of them when used as intended. Comprehensive policy change, product regulation and litigation is required to put a halt to the tobacco industry's decades of avoidance, delay and disruption of tobacco control. In an interview for the Wall Stre ....Tobacco use continues to be both the most important preventable cause of premature death and a key determinant of health inequity in Australia. Tobacco is a legally sold product which addicts many of its consumers, mostly as adolescents, and then kills half of them when used as intended. Comprehensive policy change, product regulation and litigation is required to put a halt to the tobacco industry's decades of avoidance, delay and disruption of tobacco control. In an interview for the Wall Street Journal in 1995, Stan Glantz, from the University of California at San Francisco, equated the tobacco industry with other disease vectors: If you want to do something about malaria, you have to study mosquitoes and if you want to do something about lung cancer, you have to study the tobacco industry. Regulatory changes can only be justified by specific local evidence of both the private plans and knowledge of the tobacco industry to attack tobacco control and their public statements and actions designed to mislead consumers and effectively prevent or delay tobacco control. This study will document the public actions and statements of the tobacco industry in Australia between 1970 and 2000. It will draw on interviews with and personal records of tobacco control experts and former state and federal health ministers; as well as tobacco retail trade publications; print media reports; material obtained via Freedom of Information from State and Federal Health Departments; Federal Cabinet papers released under the 30 year rule (ie papers are available from prior 1972); and radio and television reports. It will complement a parallel study of the tobacco industry's internal documents. The outcome will be provision of strategically vital evidence to support effective tobacco control advocacy, policy formation, regulation and litigation in Australia, in the face of continuing industry countermeasures.Read moreRead less
Deconstructing DTCA: Towards A Differentiated Policy Response To Direct-to-Consumer Advertising In Australia.
Funder
National Health and Medical Research Council
Funding Amount
$190,760.00
Summary
Spending on prescription pharmaceuticals is the fastest growing part of the health budget. In recent years attention has shifted to the impact of direct-to-consumer advertising (DTCA) on consumer demand and drug costs. Although DTCA is prohibited in Australia, it is clear that different types of DTCA are occurring. This study will examine the nature and range of DTCA, review the benefits and harms of DTCA, and identify the perspectives of major stakeholders regarding DTCA. The study will culmina ....Spending on prescription pharmaceuticals is the fastest growing part of the health budget. In recent years attention has shifted to the impact of direct-to-consumer advertising (DTCA) on consumer demand and drug costs. Although DTCA is prohibited in Australia, it is clear that different types of DTCA are occurring. This study will examine the nature and range of DTCA, review the benefits and harms of DTCA, and identify the perspectives of major stakeholders regarding DTCA. The study will culminate in a national workshop which will develop a differentiated set of recommendations for responding to different types and modes of DTCA. This is likely to lead to better health policy and to resources that may assist consumers and health professionals deal with DTCA.Read moreRead less
Optical Vortices For Trapping And Guiding Nanoparticles In Air
Funder
National Health and Medical Research Council
Funding Amount
$500,685.00
Summary
A serious challenge for environmental protection in the fast-growing nanotechnology industry is the development of new methods for effective removal of nanoparticle contamination, which may pose hazards to humans, from air. We will develop new laser-based methods for effective capture and removal of nanoparticulate pollutants from air, which will find wide-spread application in developing ecologically clean and health-safe environments for the Australian and world-wide nanotechnology industry.